156 related articles for article (PubMed ID: 37870438)
1. Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors.
Galbraith K; Serrano J; Shen G; Tran I; Slocum CC; Ketchum C; Abdullaev Z; Turakulov R; Bale T; Ladanyi M; Sukhadia P; Zaidinski M; Mullaney K; DiNapoli S; Liechty BL; Barbaro M; Allen JC; Gardner SL; Wisoff J; Harter D; Hidalgo ET; Golfinos JG; Orringer DA; Aldape K; Benhamida J; Wrzeszczynski KO; Jour G; Snuderl M
Mol Cancer Res; 2024 Jan; 22(1):21-28. PubMed ID: 37870438
[TBL] [Abstract][Full Text] [Related]
2. The spectrum of rare central nervous system (CNS) tumors with EWSR1-non-ETS fusions: experience from three pediatric institutions with review of the literature.
Lopez-Nunez O; Cafferata B; Santi M; Ranganathan S; Pearce TM; Kulich SM; Bailey KM; Broniscer A; Rossi S; Zin A; Nasrallah MP; Li MM; Zhong Y; Miele E; Alaggio R; Surrey LF
Brain Pathol; 2021 Jan; 31(1):70-83. PubMed ID: 32997853
[TBL] [Abstract][Full Text] [Related]
3. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract][Full Text] [Related]
4. Landscape of gene fusions in epithelial cancers: seq and ye shall find.
Kumar-Sinha C; Kalyana-Sundaram S; Chinnaiyan AM
Genome Med; 2015 Dec; 7():129. PubMed ID: 26684754
[TBL] [Abstract][Full Text] [Related]
5. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.
Alhalabi KT; Stichel D; Sievers P; Peterziel H; Sommerkamp AC; Sturm D; Wittmann A; Sill M; Jäger N; Beck P; Pajtler KW; Snuderl M; Jour G; Delorenzo M; Martin AM; Levy A; Dalvi N; Hansford JR; Gottardo NG; Uro-Coste E; Maurage CA; Godfraind C; Vandenbos F; Pietsch T; Kramm C; Filippidou M; Kattamis A; Jones C; Øra I; Mikkelsen TS; Zapotocky M; Sumerauer D; Scheie D; McCabe M; Wesseling P; Tops BBJ; Kranendonk MEG; Karajannis MA; Bouvier N; Papaemmanuil E; Dohmen H; Acker T; von Hoff K; Schmid S; Miele E; Filipski K; Kitanovski L; Krskova L; Gojo J; Haberler C; Alvaro F; Ecker J; Selt F; Milde T; Witt O; Oehme I; Kool M; von Deimling A; Korshunov A; Pfister SM; Sahm F; Jones DTW
Acta Neuropathol; 2021 Nov; 142(5):841-857. PubMed ID: 34417833
[TBL] [Abstract][Full Text] [Related]
6. Targeted next generation sequencing of MLH1-deficient, MLH1 promoter hypermethylated, and BRAF/RAS-wild-type colorectal adenocarcinomas is effective in detecting tumors with actionable oncogenic gene fusions.
Vaňková B; Vaněček T; Ptáková N; Hájková V; Dušek M; Michal M; Švajdler P; Daum O; Daumová M; Michal M; Mezencev R; Švajdler M
Genes Chromosomes Cancer; 2020 Oct; 59(10):562-568. PubMed ID: 32427409
[TBL] [Abstract][Full Text] [Related]
7. Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA.
Hou Y; Pinheiro J; Sahm F; Reuss DE; Schrimpf D; Stichel D; Casalini B; Koelsche C; Sievers P; Wefers AK; Reinhardt A; Ebrahimi A; Fernández-Klett F; Pusch S; Meier J; Schweizer L; Paulus W; Prinz M; Hartmann C; Plate KH; Reifenberger G; Pietsch T; Varlet P; Pagès M; Schüller U; Scheie D; de Stricker K; Frank S; Hench J; Pollo B; Brandner S; Unterberg A; Pfister SM; Jones DTW; Korshunov A; Wick W; Capper D; Blümcke I; von Deimling A; Bertero L
Acta Neuropathol; 2019 May; 137(5):837-846. PubMed ID: 30759284
[TBL] [Abstract][Full Text] [Related]
8. The landscape and therapeutic relevance of cancer-associated transcript fusions.
Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
[TBL] [Abstract][Full Text] [Related]
9. Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions.
Stichel D; Schrimpf D; Casalini B; Meyer J; Wefers AK; Sievers P; Korshunov A; Koelsche C; Reuss DE; Reinhardt A; Ebrahimi A; Fernández-Klett F; Kessler T; Sturm D; Ecker J; Milde T; Herold-Mende C; Witt O; Pfister SM; Wick W; Jones DTW; von Deimling A; Sahm F
Acta Neuropathol; 2019 Nov; 138(5):827-835. PubMed ID: 31278449
[TBL] [Abstract][Full Text] [Related]
10. Accurate calling of KIAA1549-BRAF fusions from DNA of human brain tumours using methylation array-based copy number and gene panel sequencing data.
Stichel D; Schrimpf D; Sievers P; Reinhardt A; Suwala AK; Sill M; Reuss DE; Korshunov A; Casalini BM; Sommerkamp AC; Ecker J; Selt F; Sturm D; Gnekow A; Koch A; Simon M; Hernáiz Driever P; Schüller U; Capper D; van Tilburg CM; Witt O; Milde T; Pfister SM; Jones DTW; von Deimling A; Sahm F; Wefers AK
Neuropathol Appl Neurobiol; 2021 Apr; 47(3):406-414. PubMed ID: 33336421
[TBL] [Abstract][Full Text] [Related]
11. Intracranial myxoid mesenchymal tumors with EWSR1-CREB family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity?
Bale TA; Oviedo A; Kozakewich H; Giannini C; Davineni PK; Ligon K; Alexandrescu S
Brain Pathol; 2018 Mar; 28(2):183-191. PubMed ID: 28281318
[TBL] [Abstract][Full Text] [Related]
12. Molecular and clinicopathologic features of gliomas harboring NTRK fusions.
Torre M; Vasudevaraja V; Serrano J; DeLorenzo M; Malinowski S; Blandin AF; Pages M; Ligon AH; Dong F; Meredith DM; Nasrallah MP; Horbinski C; Dahiya S; Ligon KL; Santi M; Ramkissoon SH; Filbin MG; Snuderl M; Alexandrescu S
Acta Neuropathol Commun; 2020 Jul; 8(1):107. PubMed ID: 32665022
[TBL] [Abstract][Full Text] [Related]
13. The Diagnostic Value of Pan-Trk Expression to Detect Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion in CNS Tumours: A Study Using Next-Generation Sequencing Platform.
Mohamed F; Kurdi M; Baeesa S; Sabbagh AJ; Hakamy S; Maghrabi Y; Alshedokhi M; Dallol A; Halawa TF; Najjar AA; Fdl-Elmula I
Pathol Oncol Res; 2022; 28():1610233. PubMed ID: 35295612
[No Abstract] [Full Text] [Related]
14. FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma.
Sievers P; Stichel D; Schrimpf D; Sahm F; Koelsche C; Reuss DE; Wefers AK; Reinhardt A; Huang K; Ebrahimi A; Hou Y; Pajtler KW; Pfister SM; Hasselblatt M; Stummer W; Schick U; Hartmann C; Hagel C; Staszewski O; Reifenberger G; Beschorner R; Coras R; Keyvani K; Kohlhof P; Diomedi-Camassei F; Herold-Mende C; Giangaspero F; Rushing E; Giannini C; Korshunov A; Jones DTW; von Deimling A
Acta Neuropathol; 2018 Aug; 136(2):293-302. PubMed ID: 29978331
[TBL] [Abstract][Full Text] [Related]
15. NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.
Solomon JP; Linkov I; Rosado A; Mullaney K; Rosen EY; Frosina D; Jungbluth AA; Zehir A; Benayed R; Drilon A; Hyman DM; Ladanyi M; Sireci AN; Hechtman JF
Mod Pathol; 2020 Jan; 33(1):38-46. PubMed ID: 31375766
[TBL] [Abstract][Full Text] [Related]
16. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.
Lake JA; Donson AM; Prince E; Davies KD; Nellan A; Green AL; Mulcahy Levy J; Dorris K; Vibhakar R; Hankinson TC; Foreman NK; Ewalt MD; Kleinschmidt-DeMasters BK; Hoffman LM; Gilani A
Pediatr Blood Cancer; 2020 Jan; 67(1):e28028. PubMed ID: 31595628
[TBL] [Abstract][Full Text] [Related]
17. Novel and established EWSR1 gene fusions and associations identified by next-generation sequencing and fluorescence in-situ hybridization.
Krystel-Whittemore M; Taylor MS; Rivera M; Lennerz JK; Le LP; Dias-Santagata D; Iafrate AJ; Deshpande V; Chebib I; Nielsen GP; Wu CL; Nardi V
Hum Pathol; 2019 Nov; 93():65-73. PubMed ID: 31430493
[TBL] [Abstract][Full Text] [Related]
18. Detection of Novel NRG1, EGFR, and MET Fusions in Lung Adenocarcinomas in the Chinese Population.
Pan Y; Zhang Y; Ye T; Zhao Y; Gao Z; Yuan H; Zheng D; Zheng S; Li H; Li Y; Jin Y; Sun Y; Chen H
J Thorac Oncol; 2019 Nov; 14(11):2003-2008. PubMed ID: 31382039
[TBL] [Abstract][Full Text] [Related]
19. Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms.
Sloan EA; Chiang J; Villanueva-Meyer JE; Alexandrescu S; Eschbacher JM; Wang W; Mafra M; Ud Din N; Carr-Boyd E; Watson M; Punsoni M; Oviedo A; Gilani A; Kleinschmidt-DeMasters BK; Coss DJ; Lopes MB; Raffel C; Berger MS; Chang SM; Reddy A; Ramani B; Ferris SP; Lee JC; Hofmann JW; Cho SJ; Horvai AE; Pekmezci M; Tihan T; Bollen AW; Rodriguez FJ; Ellison DW; Perry A; Solomon DA
Brain Pathol; 2021 Jul; 31(4):e12918. PubMed ID: 33141488
[TBL] [Abstract][Full Text] [Related]
20. Cell block-based RNA next generation sequencing for detection of gene fusions in lung adenocarcinoma: An institutional experience.
Wei S; Talarchek JN; Huang M; Gong Y; Du F; Ehya H; Flieder DB; Patchefsky AS; Wasik MA; Pei J
Cytopathology; 2023 Jan; 34(1):28-34. PubMed ID: 36062384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
